CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,384,247
- in 9 filings, $4.7M under 10b5-1 plans
Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-08-13 | KNOTT DAVID M Director | Sale | −27,300 | $96.20 | $2.6M | 196,186 |
| 2015-08-13 | KNOTT DAVID M Director | Sale | −7,225 | $96.20 | $695K | 30,771 |
| 2015-08-12 | KNOTT DAVID M Director | Sale | −800 | $96.45 | $77K | 971,300 |
| 2015-08-12 | KNOTT DAVID M Director | Sale | −9,875 | $96.45 | $952K | 223,486 |
| 2015-08-12 | KNOTT DAVID M Director | Sale | −2,600 | $96.45 | $251K | 37,996 |
| 2015-08-07 | KNOTT DAVID M Director | Sale | −200 | $99.02 | $20K | 40,596 |
| 2015-08-06 | Korenberg Matthew E VP, Finance and CFO | Grant or award | +6,000 | 6,000 | ||
| 2015-08-06 | Korenberg Matthew E VP, Finance and CFO | Grant or award · Employee Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2015-08-06 | HIGGINS JOHN L Chief Executive Officer | Sale | −4,666 | $110.79 | $517K | 121,378 |
| 2015-08-06 | Davis Todd C Director | Exercise or conversion | +2,500 | $17.88 | $45K | 38,279 |
| 2015-08-06 | Davis Todd C Director | Exercise or conversion | +2,500 | $8.58 | $21K | 40,779 |
| 2015-08-06 | Davis Todd C Director | Exercise or conversion | +7,335 | $10.12 | $74K | 48,114 |
| 2015-08-06 | Davis Todd C Director | Exercise or conversion | +7,335 | $12.53 | $92K | 55,449 |
| 2015-08-06 | Davis Todd C Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −2,500 | 0 | ||
| 2015-08-06 | Davis Todd C Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −7,335 | 0 | ||
| 2015-08-06 | Davis Todd C Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −7,335 | 0 | ||
| 2015-08-06 | Davis Todd C Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −2,500 | 0 | ||
| 2015-07-13 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion | +1,000 | $53.10 | $53K | 27,454 |
| 2015-07-13 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion · Employee Stock Option (right to buy) | −1,000 | 0 | ||
| 2015-07-10 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion | +5,625 | $10.05 | $57K | 32,079 |
Page 66 of 86 · 1,712 trades